Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BD Manufacturing Realignment To Affect Up To 1,000 Employees

This article was originally published in The Gray Sheet

Executive Summary

Restructuring plans announced by Becton Dickinson May 19 are expected to include the realignment of certain manufacturing operations and layoffs or reassignment of 500 to 1,000 manufacturing personnel, the company says.

You may also be interested in...

BD Eliminates Distributor Incentives, 1,000 Jobs In Restructuring Initiative

Becton Dickinson's plan to eliminate certain distributor incentive programs that create unpredictability and inefficiency in inventory management will cost the firm about $50 mil. in FY 2000 fourth-quarter revenues and cut earnings by six cents per share, the company announced Sept. 26.

US FDA Not Changing Assessment Goals Because of Coronavirus-Mandated Telework

Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts